Literature DB >> 29334048

Use of the Real Time xCelligence System for Purposes of Medical Microbiology.

Adam Feliks Junka1, Adriana Janczura1, Danuta Smutnicka1, Beata Mączyńska1, Secewicz Anna1, Joanna Nowicka1, Marzenna Bartoszewicz1, Grażyna Gościniak1.   

Abstract

Roche's xCelligence impedance-measuring instrument is one of a few commercially available systems of such type. According to the best knowledge of authors, instrument was tested so far only for eukaryotic cell research. The aim of this work was to estimate xCELLigence suitability for the microbiological tests, including (i) measurement of morphological changes in eukaryotic cells as a result of bacterial toxin activity, (ii) measurement of bacterial biofilm formation and (iii) impact of antiseptics on the biofilm structure. To test the infuence of bacterial LT enterotoxin on eukaryotic cell lines, Chinese Hamster Ovary (CHO) cell line and reference strain Escherichia coli ATTC 35401 were used. To investigate Roche's instrument ability to measure biofilm formation and impact of antiseptics on its development, Staphylococcus aureus ATTC6538 reference strain was used. The data generated during the experiments indicate excellent ability of xCelligence instrument to detect cytopathic effect caused by bacterial LT endotoxin and to detect staphylococcal biofilm formation. However, interpretation of the results obtained during real-time measurement of antiseptic's bactericidal activity against staphylococcal biofilm, caused many difficulties. xCelligence instrument can be used for real-time monitoring of morphological changes in CHO cells treated with bacterial LT enterotoxin and for real-time measurement of staphylococcal biofilm formation in vitro. Further investigation is necessary to confirm suitability of system to analyze antiseptic's antimicrobial activity against biofilm in vitro.

Entities:  

Keywords:  morphological changes in CHO cells; staphylococcal biofilm formation in vitro; xCelligence real-time measurement

Year:  2012        PMID: 29334048

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  7 in total

1.  Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.

Authors:  Evan F Haney; Michael J Trimble; John T Cheng; Quentin Vallé; Robert E W Hancock
Journal:  Biomolecules       Date:  2018-05-21

2.  Staphylococcus aureus and MRSA Growth and Biofilm Formation after Treatment with Antibiotics and SeNPs.

Authors:  Kristyna Cihalova; Dagmar Chudobova; Petr Michalek; Amitava Moulick; Roman Guran; Pavel Kopel; Vojtech Adam; Rene Kizek
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

3.  Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology.

Authors:  Diana Gutiérrez; Claudio Hidalgo-Cantabrana; Ana Rodríguez; Pilar García; Patricia Ruas-Madiedo
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

4.  Inhibition of Steptococcus mutans biofilm formation by extracts of Tenacibaculum sp. 20J, a bacterium with wide-spectrum quorum quenching activity.

Authors:  Andrea Muras; Celia Mayer; Manuel Romero; Tamara Camino; Maria D Ferrer; Alex Mira; Ana Otero
Journal:  J Oral Microbiol       Date:  2018-01-30       Impact factor: 5.474

5.  Nitrate as a potential prebiotic for the oral microbiome.

Authors:  B T Rosier; E Buetas; E M Moya-Gonzalvez; A Artacho; Alex Mira
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

6.  Candida albicans Biofilm Heterogeneity and Tolerance of Clinical Isolates: Implications for Secondary Endodontic Infections.

Authors:  Om Alkhir Alshanta; Suror Shaban; Christopher J Nile; William McLean; Gordon Ramage
Journal:  Antibiotics (Basel)       Date:  2019-10-30

7.  In Vitro Evaluation of the Cytotoxic Effect of Streptococcus pyogenes Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line.

Authors:  Alexandr N Chernov; Anna Tsapieva; Diana A Alaverdian; Tatiana A Filatenkova; Elvira S Galimova; Mariia Suvorova; Olga V Shamova; Alexander N Suvorov
Journal:  Molecules       Date:  2022-01-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.